Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery

This publication has 235 references indexed in Scilit:

• Estrogen receptor signaling as a target for novel breast cancer therapeutics
  Biochemical Pharmacology, 2013
• Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells
  European Journal of Pharmacology, 2010
• Mitochondria and cell death: outer membrane permeabilization and beyond
  Nature Reviews Molecular Cell Biology, 2010
• The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients
  Journal of Clinical Investigation, 2010
• Direct control of mitochondrial function by mTOR
  Proceedings of the National Academy of Sciences, 2009
• Gallic Acid, an Active Constituent of Grape Seed Extract, Exhibits Anti-proliferative, Pro-apoptotic and Anti-tumorigenic Effects Against Prostate Carcinoma Xenograft Growth in Nude Mice
  Pharmaceutical Research, 2009
• The Many Roles of FAS Receptor Signaling in the Immune System
  Immunity, 2009
• Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma
  British Journal of Haematology, 2008
• Death through a tragedy: mitotic catastrophe
  Cell Death & Differentiation, 2008
• Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
  Proceedings of the National Academy of Sciences, 2008